 |
CTSI Update: Announcement |
|
|
|
|
Now Accepting Applications for Fall 2021 |
Training for Bench, Clinical, Biomedical, Translational
and Population Health Researchers
|
Are you planning to submit a Career Development Award? Have you assembled mentors and developed a Specific Aims page, but want to ensure that you submit the most competitive application possible? The Career Development Award Grant Writing Workshop, sponsored by the BU CTSI, is open to Faculty and accomplished Post-doctoral Students/Fellows who will be remaining at BUMC.
|
|
|
|
|
Research to Reality:
Human-Centered Approaches to Recruitment and Retention
|
Jun. 28, 2021, 12 - 1 p.m
The goal of this series is to provide an understanding of the ethical background, regulatory knowledge, and models of best practices for conducting research when the participants represent special populations and vulnerable subjects.
|
|
|
|
Now Accepting Applications
Application Closes: Sep. 6, 2021
The overarching goal of the BU CTSI Pilot Grant Program is to help investigators explore and solve major challenges in translational science, especially those that address the special health problems of our urban communities, by developing and deploying new tools, methods, and processes to expedite clinical and translational research and discovery.
|
|
|
|
|
New Funding Opportunities |
|
|
|
|
Notice of Special Interest (NOSI): Administrative Supplements to NIMHD Awards for Research on HIV/AIDS in Populations that Experience Health Disparities (Admin Supp Clinical Trial Optional)
National Institute on Minority Health and Health Disparities (NIMHD)
|
HEAL Initiative: Planning Studies for Initial Analgesic Development [Small Molecules and Biologics] (R61 Clinical Trial Not Allowed)
National Institute of Neurological Disorders and Stroke (NINDS)
|
Notice of a Pre-Application Informational Webinar for PAR-21-168 "Summer Research Education Experience Program (R25 Clinical Trial Not Allowed)"
National Institute of Neurological Disorders and Stroke (NINDS)
|
|
|
|
Integration, Dissemination, and Evaluation (BRIDGE) Center for the NIH Bridge to Artificial Intelligence (Bridge2AI) Program (U54 Clinical Trial Not Allowed)
|
Exploratory Studies to Investigate the Mechanisms of Interrelationship Between Sleep and Substance Use Disorders (R61/R33 Clinical Trials Not Allowed)
|
Notice of Participation of NINR in PA-21-050, “Ruth L. Kirschstein National Research Service Award (NRSA) Individual Fellowship for Students at Institutions Without NIH-Funded Institutional Predoctoral Dual-Degree Training Programs
National Institute of Nursing Research (NINR)
|
|
|
|
Notice of Special Interest (NOSI) to Encourage Administrative Supplement Applications to Investigate COVID-19 Vaccination and Menstruation (Admin Supp – Clinical Trial Optional)
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
|
BRAIN Initiative: Optimization of Transformative Technologies for Recording and Modulation in the Nervous System (U01 Clinical Trials Not Allowed)
National Institute of Neurological Disorders and Stroke (NINDS)
|
Mobile Health Solutions to rectify digital inequality in communities affected by drug addiction (R43/R44 Clinical Trial Optional)
National Institute on Drug Abuse (NIDA)
|
|
|
|
|
RADx Tech II: Fast-Track Program to Advance U.S. COVID-19 Testing Capabilities
This is to further advance SARS-CoV-2 testing technologies for specific unmet national needs. Which, include point-of-care/over-the-counter tests with the performance of lab-based tests, tests for multiple pathogens, and tests adaptable to emerging variants. Apply Here
|
|
|
|
|
How COVID-19 Can Lead to Diabetes
Along with pneumonia, blood clots, and other serious health concerns caused by SARS-CoV-2, the COVID-19 virus, some studies have also identified another troubling connection. Some people can develop diabetes after an acute COVID-19 infection. Read More
|
|
|
|
|
COVID-19 Vaccines May Be Less Effective
in Some People with Cancer
some people with cancer may not be as protected by the vaccine as people without the disease, results from three new studies suggest. Read More
|
|
|
|
|
Could a Nasal Spray of Designer Antibodies Help to Beat COVID-19?
There are now several monoclonal antibodies, identical copies of a therapeutic antibody produced in large numbers, that are authorized for the treatment of COVID-19. Read More
|
|
|
|
|
How COVID-19 Variants Evade Immune Response
SARS-CoV-2, the virus that causes COVID-19, uses a protein called the spike protein to recognize and enter host cells. Recent SARS-CoV-2 variants contain changes, or mutations, at a key site on the spike protein called the receptor-binding site (RBS). Read More
|
|
|
|
|
The CLIC Career Development Community Has Launched!
Join any of the three focus areas now to collaborate, network, and share ideas with your peers. Each focus area includes a message board, community content feed, and searchable community member list to foster communication across the consortium. Read More
|
|
|
|
|
NIH Pain Consortium Grant - Mechanism Webinar Series.
The National Institutes of Health (NIH) Pain Consortium is holding a webinar series on the types of grants available for pain research for investigators at different stages of their careers. Read More
|
|
|
|
|
Online Course in Translational Science
Jun. 14 - July 30, 2021
|
|
|
|
|
Pooling Overview, Key Development Challenges for Central Laboratories
and Point of Care (POC) Solutions, Regulatory Guidance for Pooling,
and Implementation Examples
Jun. 15, 2021, 2 p.m.
A multi-disciplinary RADx Pooling Task Force has been created to engage with the FDA, CMS, and CDC to address COVID-19 pooling practices and develop guidance for both laboratory and point-of-care (POC) settings. Importantly, there is no existing EUA regulatory guidance for POC pooling, and there are no approved POC pooling solutions available on the market. The presentation will be a high-level overview of COVID-19 pooling with examples, implementation challenges, and regulatory requirements and solutions. Read More
|
|
|
|
|
The Funding Acknowledgement |
|
|
|
|
The Funding Acknowledgement guides recipients of BU CTSI services, resources, or funding for projects or research through the grant citation process. All recipients are required to cite our grant number in associated presentations and journal publications.
|
|
|
|
|
|
|
|
|
